FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Junker

Research Profile

Disorders

Chemicals & Drugs

Geographic Areas

Denmark

Concepts & Ideas

Physiology

Disease Progression

Living Beings

Young Adult

Co-author Network

Publications

TOP 3
Merete Lund Hetland; Kim Hørslev-Petersen; Søren Jacobsen; Peter Junker; Hanne Merete Lindegaard; Tine Lottenburger; Jens Kristian Pedersen; Jan Pødenphant; Henrik Skjødt; Kristian Stengaard-Pedersen; Anders Svendsen; Ulrik Tarp; Mikkel Ostergaard; Lis Smedegaard Andersen; Bo Ejbjerg; Torkell Ellingsen; Ib Hansen
Short- and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRP.
A F Christensen; S V Hoegh; Uffe Holmskov; Kim Hørslev-Petersen; Tine Lottenburger; Grith L Sørensen; Ida Tornoe; Peter Junker
Circadian rhythm and the influence of physical activity on circulating surfactant protein D in early and long-standing rheumatoid arthritis.
Mikkel Ostergaard; Jan Pødenphant; Kristian Stengaard-Pedersen; Anne Duer-Jensen; Merete Lund Hetland; Kim Hørslev-Petersen; Peter Junker; Uffe Møller Døhn; Bo Ejbjerg
Patterns of magnetic resonance imaging bone erosion in rheumatoid arthritis--which bones are most frequently involved and show the most change?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Junker (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Merete Lund Hetland; Kim Hørslev-Petersen; Søren Jacobsen; Peter Junker; Hanne Merete Lindegaard; Tine Lottenburger; Jens Kristian Pedersen; Jan Pødenphant; Henrik Skjødt; Kristian Stengaard-Pedersen; Anders Svendsen; Ulrik Tarp; Mikkel Ostergaard; Lis Smedegaard Andersen; Bo Ejbjerg; Torkell Ellingsen; Ib Hansen
Short- and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRP.
Annals of the rheumatic diseases 2012;71(6):851-6.
2011: A F Christensen; S V Hoegh; Uffe Holmskov; Kim Hørslev-Petersen; Tine Lottenburger; Grith L Sørensen; Ida Tornoe; Peter Junker
Circadian rhythm and the influence of physical activity on circulating surfactant protein D in early and long-standing rheumatoid arthritis.
Rheumatology international 2011;31(12):1617-23.
2011: Mikkel Ostergaard; Jan Pødenphant; Kristian Stengaard-Pedersen; Anne Duer-Jensen; Merete Lund Hetland; Kim Hørslev-Petersen; Peter Junker; Uffe Møller Døhn; Bo Ejbjerg
Patterns of magnetic resonance imaging bone erosion in rheumatoid arthritis--which bones are most frequently involved and show the most change?
The Journal of rheumatology 2011;38(9):2014-7.
2011: Belinda K Moessner; Tina R Jørgensen; Merete Skamling; Mogens Vyberg; Peter Junker; Court Pedersen; Peer B Christensen
Outreach screening of drug users for cirrhosis with transient elastography.
Addiction (Abingdon, England) 2011;106(5):970-6.
2011: Anna Christine Nilsson; Anne Friesgaard Christensen; Peter Junker; Hanne Merete Lindegaard
Tumour necrosis factor-α inhibitors are glucocorticoid-sparing in rheumatoid arthritis.
Danish medical bulletin 2011;58(4):A4257.
2011: Søren Andreas Just; John Bonde Knudsen; Mie Kiszka Nielsen; Peter Junker
Wegener's granulomatosis presenting with pachymeningitis: clinical and imaging remission by rituximab.
ISRN rheumatology 2011;2011():608942.
2010: Merete Lund Hetland; Kristian Stengaard-Pedersen; Peter Junker; Mikkel Østergaard; Bo Ejbjerg; Søren Jacobsen; Tine Lottenburger; Ib Hansen; Ulrik Tarp; Lis Smedegaard Andersen; Anders Svendsen; Jens K Pedersen; Ulrik B Lauridsen; Torkell Ellingsen; Hanne Merete Lindegaard; Jan Pødenphant; Aage Vestergaard; Anne Grethe Jurik; Kim Hørslev-Petersen
Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial.
Annals of the rheumatic diseases 2010;69(10):1789-95.
2010: Anne Friesgaard Christensen; Kim Hørslev-Petersen; Stephan Christgau; Hanne Merete Lindegaard; Tine Lottenburger; Kirsten Junker; Merete Lund Hetland; Kristian Stengaard-Pedersen; Søren Jacobsen; Torkell Ellingsen; Lis Smedegaard Andersen; Ib Hansen; Henrik Skjødt; Jens Kristian Pedersen; Ulrik Birk Lauridsen; Anders Jørgen Svendsen; Ulrik Tarp; Jan Pødenphant; Niels H H Heegaard; Aage Vestergaard; Anne Grethe Jurik; Mikkel Ostergaard; Peter Junker
Uncoupling of collagen II metabolism in newly diagnosed, untreated rheumatoid arthritis is linked to inflammation and antibodies against cyclic citrullinated peptides.
The Journal of rheumatology 2010;37(6):1113-20.
2010: Silje Vermedal Hoegh; Grith Lykke Sorensen; Ida Tornoe; Tine Lottenburger; Henriette Ytting; Hans Jørgen Nielsen; Peter Junker; Uffe Holmskov
Long-term stability and circadian variation in circulating levels of surfactant protein D.
Immunobiology 2010;215(4):314-20.
2010: Henrik K Laustrup; A Voss; Anders Green; Peter Junker
SLE disease patterns in a Danish population-based lupus cohort: an 8-year prospective study.
Lupus 2010;19(3):239-46.
2010: Anne Friesgaard Christensen; T Lottenburger; Hanne Merete Lindegaard; K Junker; Kim Hørslev-Petersen; Peter Junker
Circadian pattern and the effect of standardized physical exercise on procollagen IIA N-peptide (PIIANP) in rheumatoid arthritis at different stages and in healthy individuals.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2010;15(1):80-5.
2010: Anne Friesgaard Christensen; Grith Lykke Sørensen; Kim Hørslev-Petersen; Uffe Holmskov; Hanne Merete Lindegaard; Kirsten Junker; Merete Lund Hetland; Kristian Stengaard-Pedersen; Søren Jacobsen; Tine Lottenburger; Torkell Ellingsen; Lis Smedegaard Andersen; Ib Hansen; Henrik Skjødt; Jens Kristian Pedersen; Ulrik Birk Lauridsen; Anders Svendsen; Ulrik Tarp; Jan Pødenphant; Aage Vestergaard; Anne Grethe Jurik; Mikkel Østergaard; Peter Junker
Circulating surfactant protein -D is low and correlates negatively with systemic inflammation in early, untreated rheumatoid arthritis.
Arthritis research & therapy 2010;12(2):R39.
2009: Silje Vermedal Hoegh; Anne Voss; Grith L Sorensen; Anette Høj; Christian Bendixen; Peter Junker; Uffe Holmskov
Circulating surfactant protein D is decreased in systemic lupus erythematosus.
The Journal of rheumatology 2009;36(11):2449-53.
2009: Søren Jacobsen; Peter Garred; Hans O Madsen; Niels H H Heegaard; Merete Lund Hetland; Kristian Stengaard-Pedersen; Peter Junker; Tine Lottenburger; Torkel Ellingsen; Lis Smedegaard Andersen; Ib Hansen; Henrik Skjødt; Jens Kristian Pedersen; Ulrik Birk Lauridsen; Anders J Svendsen; Ulrik Tarp; Jan Pødenphant; Hanne Lindegaard; Aage Vestergaard; Mikkel Østergaard; Kim Hørslev-Petersen
Mannose-binding lectin gene polymorphisms are associated with disease activity and physical disability in untreated, anti-cyclic citrullinated peptide-positive patients with early rheumatoid arthritis.
The Journal of rheumatology 2009;36(4):731-5.
2009: Henrik K Laustrup; A Voss; Anders Green; Peter Junker
Occurrence of systemic lupus erythematosus in a Danish community: an 8-year prospective study.
Scandinavian journal of rheumatology 2009;38(2):128-32.
2009: Merete Lund Hetland; Bo Ejbjerg; Kim Hørslev-Petersen; Steffen Jacobsen; Aage Vestergaard; Anne Grethe Jurik; K Stengaard-Pedersen; Peter Junker; Tine Lottenburger; I Hansen; Lis Smedegaard Andersen; Ulrik Tarp; Henrik Skjødt; J K Pedersen; O Majgaard; Anders Svendsen; T Ellingsen; Hanne Merete Lindegaard; A F Christensen; J Vallø; T Torfing; Eva Narvestad; Henrik S Thomsen; Mikkel Ostergaard
MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA).
Annals of the rheumatic diseases 2009;68(3):384-90.
2009: Ulla Slothuus Skjoldborg; Jørgen Lauridsen; Peter Junker
Reliability of the discrete choice experiment at the input and output level in patients with rheumatoid arthritis.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2009;12(1):153-8.
2008: O B Pedersen; Anders Svendsen; L Ejstrup; Axel Skytthe; Peter Junker
On the heritability of psoriatic arthritis. Disease concordance among monozygotic and dizygotic twins.
Annals of the rheumatic diseases 2008;67(10):1417-21.
2008: O B V Pedersen; Anders Svendsen; L Ejstrup; Axel Skytthe; Peter Junker
The occurrence of psoriatic arthritis in Denmark.
Annals of the rheumatic diseases 2008;67(10):1422-6.
2008: Anne Friesgaard Christensen; Hanne Merete Lindegaard; Peter Junker
[Smoking--a risk factor for rheumatoid arthritis development].
Ugeskrift for laeger 2008;170(37):2864-9.
2008: Sergey V Kozyrev; Anna-Karin Abelson; Jerome Wojcik; Ammar Zaghlool; Mv Prasad Linga Reddy; Elena Sanchez; Iva Gunnarsson; Elisabet Svenungsson; Gunnar Sturfelt; Andreas Jönsen; Lennart Truedsson; Bernardo A Pons-Estel; Torsten Witte; Sandra D'Alfonso; Nadia Barrizzone; Maria Giovanna Danieli; Carmen Gutierrez; Ana Suarez; Peter Junker; Henrik K Laustrup; Maria Francisca González-Escribano; Javier Martin; Hadi Abderrahim; Marta E Alarcón-Riquelme
Corrigendum: Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus.
Nature genetics 2008;40(4):484.
2008: Anne Voss; Ellen Holm Nielsen; Sven-Erik Svehag; Peter Junker
Serum amyloid P component-DNA complexes are decreased in systemic lupus erythematosus. inverse association with anti-dsDNA antibodies.
The Journal of rheumatology 2008;35(4):625-30.
2008: O B Pedersen; Anders Svendsen; L Ejstrup; Axel Skytthe; J R Harris; Peter Junker
Ankylosing spondylitis in Danish and Norwegian twins: occurrence and the relative importance of genetic vs. environmental effectors in disease causation.
Scandinavian journal of rheumatology 2008;37(2):120-6.
2008: Sergey V Kozyrev; Anna-Karin Abelson; Jerome Wojcik; Ammar Zaghlool; M V Prasad Linga Reddy; Elena Sanchez; Iva Gunnarsson; Elisabet Svenungsson; Gunnar Sturfelt; Andreas Jönsen; Lennart Truedsson; Bernardo A Pons-Estel; Torsten Witte; Sandra D'Alfonso; Nadia Barizzone; Nadia Barrizzone; Maria Giovanna Danieli; Carmen Gutierrez; Ana Suarez; Peter Junker; Henrik K Laustrup; María Francisca González-Escribano; Javier Martin; Hadi Abderrahim; Marta E Alarcón-Riquelme
Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus.
Nature genetics 2008;40(2):211-6.
2008: S V Hoegh; Hanne Merete Lindegaard; Grith L Sorensen; Anette Høj; Christian Bendixen; Peter Junker; Uffe Holmskov
Circulating surfactant protein D is decreased in early rheumatoid arthritis: a 1-year prospective study.
Scandinavian journal of immunology 2008;67(1):71-6.
2007: Louise Frederiksen; Peter Junker; Kim Brixen
[Persistent polyarticular synovitis after treatment with alendronate].
Ugeskrift for laeger 2007;169(17):1583-4.
2007: Sergey V Kozyrev; Susanna Lewén; Prasad M V Linga Reddy; Bernardo A Pons-Estel; Torsten Witte; Peter Junker; Henrik K Laustrup; Carmen Gutiérrez; Ana Suárez; Maria Francisca González-Escribano; Javier Martín; Marta E Alarcón-Riquelme
Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus.
Arthritis and rheumatism 2007;56(4):1234-41.
2007: O B Pedersen; G O Hansen; Anders Svendsen; L Ejstrup; Peter Junker
Adaptation of the Bath measures on disease activity and function in ankylosing spondylitis into Danish.
Scandinavian journal of rheumatology 2007;36(1):22-7.
2006: Hanne Merete Lindegaard; J Vallø; Kim Hørslev-Petersen; Peter Junker; Mikkel Østergaard
Low-cost, low-field dedicated extremity magnetic resonance imaging in early rheumatoid arthritis: a 1-year follow-up study.
Annals of the rheumatic diseases 2006;65(9):1208-12.
2006: Merete Lund Hetland; Kristian Stengaard-Pedersen; Peter Junker; Tine Lottenburger; Torkell Ellingsen; Lis Smedegaard Andersen; Ib Hansen; Henrik Skjødt; Jens Kristian Pedersen; Ulrik Birk Lauridsen; Anders Svendsen; Ulrik Tarp; Jan Pødenphant; Gert Hansen; Hanne Lindegaard; Anselmo de Carvalho; Mikkel Østergaard; Kim Hørslev-Petersen
Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study.
Arthritis and rheumatism 2006;54(5):1401-9.
2005: Hanne Merete Lindegaard; Kim Hørslev-Petersen; Peter Junker
[Early referral and treatment of patients with acute arthritis. Experiences from two early arthritis clinics].
Ugeskrift for laeger 2005;167(47):4458-61.
2004: Henrik K Laustrup; Niels H H Heegaard; A Voss; A Green; Søren Lillevang; Peter Junker
Autoantibodies and self-reported health complaints in relatives of systemic lupus erythematosus patients: a community based approach.
Lupus 2004;13(10):792-9.
2004: C Nielsen; Henrik K Laustrup; A Voss; Peter Junker; Steffen Husby; Søren Lillevang
A putative regulatory polymorphism in PD-1 is associated with nephropathy in a population-based cohort of systemic lupus erythematosus patients.
Lupus 2004;13(7):510-6.
2004: HC Horn; K Grau; Peter Junker
IVIG treatment for progressive stroke in the primary antiphospholipid antibody syndrome.
Lupus 2004;13(6):478-80.
2003: Rikke Leth-Larsen; Claudia Nordenbaek; Ida Tornoe; Vivi Moeller; Anders Schlosser; Claus Koch; Børge Teisner; Peter Junker; Uffe Holmskov
Surfactant protein D (SP-D) serum levels in patients with community-acquired pneumonia small star, filled.
Clinical immunology (Orlando, Fla.) 2003;108(1):29-37.
2003: Claudia Nordenbaek; Børge Teisner; Peter Junker
Connective tissue responses in acute community-acquired pneumonia.
Respiratory medicine 2003;97(6):660-6.
2002: Anders Svendsen; Niels V Holm; Kirsten Ohm Kyvik; Per Hyltoft Petersen; Peter Junker
Authors respond to criticism of rheumatoid arthritis twin study.
BMJ (Clinical research ed.) 2002;325(7360):391.
2002: Bo Abrahamsen; Jørgen Hangaard; HC Horn; Thomas B Hansen; G Gregersen; M Hansen-Nord; Nina Vahl; Peter Junker; Marianne Andersen; Claus Hagen
Evaluation of the optimum dose of growth hormone (GH) for restoring bone mass in adult-onset GH deficiency: results from two 12-month randomized studies.
Clinical endocrinology 2002;57(2):273-81.
2002: Ulla Slothuus; Mette L Larsen; Peter Junker
The contingent ranking method--a feasible and valid method when eliciting preferences for health care?
Social science & medicine (1982) 2002;54(10):1601-9.
2002: Steffen Jacobsen; Henrik Skjødt; Kim Hørslev-Petersen; Troels Mørk Hansen; Søren Freiesleben Sørensen; Jørgen Petersen; Peter Junker; Kristian Stengaard-Pedersen
[Diagnosis and treatment of early rheumatoid arthritis].
Ugeskrift for laeger 2002;164(8):1060-1.
2002: Anders Svendsen; Niels V Holm; Kirsten Ohm Kyvik; Per Hyltoft Petersen; Peter Junker
Relative importance of genetic effects in rheumatoid arthritis: historical cohort study of Danish nationwide twin population.
BMJ (Clinical research ed.) 2002;324(7332):264-6.
2001: T P Enggaard; Peter Junker
[Picture of the month: cold agglutinin syndrome and Raynaud's phenomenon].
Ugeskrift for laeger 2001;163(49):6922.
2001: Jens Kjeldsen; Morten Rasmussen; Ove B Schaffalitzky de Muckadell; Ole Kronborg; Peter Junker
Collagen metabolites in the peripheral and splanchnic circulation of patients with Crohn disease.
Scandinavian journal of gastroenterology 2001;36(11):1193-7.
2001: Hanne Merete Lindegaard; J Vallø; Kim Hørslev-Petersen; Peter Junker; Mikkel Østergaard
Low field dedicated magnetic resonance imaging in untreated rheumatoid arthritis of recent onset.
Annals of the rheumatic diseases 2001;60(8):770-6.
2001: HC Horn; P Ottosen; Peter Junker
Renal crisis in asclerodermic scleroderma--lupus overlap syndrome.
Lupus 2001;10(12):886-8.
2000: Peter Junker
[Rheumatoid arthritis--an acute medical condition].
Ugeskrift for laeger 2000;162(1):24-5.
2000: Ulla Slothuus; M L Larsen; Peter Junker
Willingness to pay for arthritis symptom alleviation. Comparison of closed-ended questions with and without follow-up.
International journal of technology assessment in health care 2000;16(1):60-72.
1999: S Schytte; M Hansen; S Møller; Peter Junker; J H Henriksen; J Hillingsø; Børge Teisner
Hepatic and renal extraction of circulating type I procollagen aminopropeptide in patients with normal liver function and in patients with alcoholic cirrhosis.
Scandinavian journal of clinical and laboratory investigation 1999;59(8):627-33.
1999: Claudia Nordenbaek; J S Johansen; Peter Junker; N Borregaard; Ole Sørensen; P A Price
YKL-40, a matrix protein of specific granules in neutrophils, is elevated in serum of patients with community-acquired pneumonia requiring hospitalization.
The Journal of infectious diseases 1999;180(5):1722-6.
1999: A B Voss; Anders Green; Peter Junker
[Systemic lupus erythematosus in the county of Fynen. An epidemiologic study].
Ugeskrift for laeger 1999;161(25):3837-40.
1999: Steffen Jacobsen; Henrik Starklint; Jørgen Petersen; S Ullman; Peter Junker; A Voss; JM Rasmussen; Ulrik Tarp; LH Poulsen; G van Overeem Hansen; B Skaarup; Troels Mørk Hansen; Jan Pødenphant; Poul Halberg
Prognostic value of renal biopsy and clinical variables in patients with lupus nephritis and normal serum creatinine.
Scandinavian journal of rheumatology 1999;28(5):288-99.
1999: Steffen Jacobsen; Jørgen Petersen; S Ullman; Peter Junker; A Voss; JM Rasmussen; Ulrik Tarp; LH Poulsen; G van Overeem Hansen; B Skaarup; Troels Mørk Hansen; Jan Pødenphant; Poul Halberg
Mortality and causes of death of 513 Danish patients with systemic lupus erythematosus.
Scandinavian journal of rheumatology 1999;28(2):75-80.
1998: Jørgen Gram; Peter Junker; H K Nielsen; Jens Bollerslev
Effects of short-term treatment with prednisolone and calcitriol on bone and mineral metabolism in normal men.
Bone 1998;23(3):297-302.
1998: Peter Junker; L Ejstrup
[Picture of the month. Psoriatic arthritis].
Ugeskrift for laeger 1998;160(31):4543.
1998: V Schantz; L L Oestergaard; Peter Junker
Shrinking spinal cord following transverse myelopathy in a patient with systemic lupus erythematosus and the phospholipid antibody syndrome.
The Journal of rheumatology 1998;25(7):1425-8.
1998: Claus Henrik Nielsen; JM Rasmussen; A Voss; Peter Junker; Robert Graham Quinton Leslie
Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes.
Arthritis and rheumatism 1998;41(4):613-22.
1998: Steffen Jacobsen; Jørgen Petersen; S Ullman; Peter Junker; A Voss; JM Rasmussen; Ulrik Tarp; LH Poulsen; G van Overeem Hansen; B Skaarup; Troels Mørk Hansen; Jan Pødenphant; Poul Halberg
A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value.
Clinical rheumatology 1998;17(6):478-84.
1998: Steffen Jacobsen; Jørgen Petersen; S Ullman; Peter Junker; A Voss; JM Rasmussen; Ulrik Tarp; LH Poulsen; G van Overeem Hansen; B Skaarup; Troels Mørk Hansen; Jan Pødenphant; Poul Halberg
A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets.
Clinical rheumatology 1998;17(6):468-77.
1998: A Voss; A Green; Peter Junker
Systemic lupus erythematosus in Denmark: clinical and epidemiological characterization of a county-based cohort.
Scandinavian journal of rheumatology 1998;27(2):98-105.
1996: Jørgen Gram; Peter Junker; H K Nielsen; Jens Bollerslev
Dose-response effect of short-term calcitriol treatment on bone and mineral metabolism in normal males.
Bone 1996;18(6):539-44.
1996: Troels Mørk Hansen; T Bendix; C E Bünger; Peter Junker; M Kosteljanetz; claus manniche; G G Rasmussen; K Stengaard-Pedersen
[Low back pain].
Ugeskrift for laeger 1996;158 Suppl 4():1-18.
1995: Jens Kjeldsen; Ove B Schaffalitzky de Muckadell; Peter Junker
Seromarkers of collagen I and III metabolism in active Crohn's disease. Relation to disease activity and response to therapy.
Gut 1995;37(6):805-10.
1995: Hanne Vibeke Marquart; A Svendsen; JM Rasmussen; Claus Henrik Nielsen; Peter Junker; Sven-Erik Svehag; Robert Graham Quinton Leslie
Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE).
Clinical and experimental immunology 1995;101(1):60-5.
1991: Jørgen Gram; Jens Bollerslev; H K Nielsen; Peter Junker
Increased serum concentrations of type I procollagen C-terminal propeptide and osteocalcin during a short course of calcitriol administration to adult male volunteers.
Acta endocrinologica 1991;125(6):609-13.
1991: I Lisse; H Hasselbalch; Peter Junker
Bone marrow stroma in idiopathic myelofibrosis and other haematological diseases. An immunohistochemical study.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1991;99(2):171-8.
1991: H Hasselbalch; Peter Junker; I Lisse; U Lindqvist; A Engström Laurent
Circulating hyaluronan in the myelofibrosis/osteomyelosclerosis syndrome and other myeloproliferative disorders.
American journal of hematology 1991;36(1):1-8.
1990: H Hasselbalch; Peter Junker; Kim Hørslev-Petersen; I Lisse; K D Bentsen
Procollagen type III aminoterminal peptide in serum in idiopathic myelofibrosis and allied conditions: relation to disease activity and effect of chemotherapy.
American journal of hematology 1990;33(1):18-26.
1988: Kim Hørslev-Petersen; K D Bentsen; P Halberg; Peter Junker; K I Kivirikko; K Majamaa; L Risteli; J Risteli; Ib Lorenzen
Connective tissue metabolites in serum as markers of disease activity in patients with rheumatoid arthritis.
Clinical and experimental rheumatology 1988;6(2):129-34.
1988: Kim Hørslev-Petersen; K D Bentsen; Peter Junker; F K Mathiesen; Troels Mørk Hansen; Ib Lorenzen
Serum aminoterminal type III procollagen peptide in inflammatory and degenerative rheumatic disorders.
Clinical rheumatology 1988;7(1):61-8.
1988: Kim Hørslev-Petersen; T Ammitzbøll; A Engström-Laurent; K Bentsen; Peter Junker; G Asboe-Hansen; Ib Lorenzen
Serum and urinary aminoterminal type III procollagen peptide in progressive systemic sclerosis: relationship to sclerodermal involvement, serum hyaluronan and urinary collagen metabolites.
The Journal of rheumatology 1988;15(3):460-7.
1988: Kim Hørslev-Petersen; K D Bentsen; A Engström-Laurent; Peter Junker; P Halberg; Ib Lorenzen
Serum amino terminal type III procollagen peptide and serum hyaluronan in rheumatoid arthritis: relation to clinical and serological parameters of inflammation during 8 and 24 months' treatment with levamisole, penicillamine, or azathioprine.
Annals of the rheumatic diseases 1988;47(2):116-26.
1988: Kim Hørslev-Petersen; T Saxne; D Haar; B S Thomsen; K D Bentsen; Peter Junker; Ib Lorenzen
The aminoterminal-type-III procollagen peptide and proteoglycans in serum and synovial fluid of patients with rheumatoid arthritis or reactive arthritis.
Rheumatology international 1988;8(1):1-9.
1987: K D Bentsen; Kim Hørslev-Petersen; Peter Junker; E Juhl; Ib Lorenzen
Serum aminoterminal procollagen type III peptide in acute viral hepatitis. A long-term follow-up study.
Liver 1987;7(2):96-105.
1986: H Hasselbalch; Peter Junker; I Lisse; K D Bentsen; L Risteli; J Risteli
Serum markers for type IV collagen and type III procollagen in the myelofibrosis-osteomyelosclerosis syndrome and other chronic myeloproliferative disorders.
American journal of hematology 1986;23(2):101-11.
1986: K D Bentsen; Kim Hørslev-Petersen; T Horn; Peter Junker
[Procollagen peptide in the serum of patients with rheumatoid arthritis and liver diseases].
Ugeskrift for laeger 1986;148(32):2011-4.
1986: K D Bentsen; Kim Hørslev-Petersen; Peter Junker
[Connective tissue metabolites in tissue fluids. New possibilities for monitoring the fibrotic process].
Ugeskrift for laeger 1986;148(32):2007-11.
1986: Kim Hørslev-Petersen; K D Bentsen; Peter Junker; Ib Lorenzen
Serum amino-terminal type III procollagen peptide in rheumatoid arthritis. Relationship to disease activity, treatment, and development of joint erosions.
Arthritis and rheumatism 1986;29(5):592-9.
1985: H Hasselbalch; Peter Junker; I Lisse; K D Bentsen
Serum procollagen III peptide in chronic myeloproliferative disorders.
Scandinavian journal of haematology 1985;35(5):550-7.